232 related articles for article (PubMed ID: 1836840)
1. Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine.
French ED; Ferkany J; Abreu M; Levenson S
Neuropharmacology; 1991 Oct; 30(10):1039-46. PubMed ID: 1836840
[TBL] [Abstract][Full Text] [Related]
2. Phencyclidine and the midbrain dopamine system: electrophysiology and behavior.
French ED
Neurotoxicol Teratol; 1994; 16(4):355-62. PubMed ID: 7968939
[TBL] [Abstract][Full Text] [Related]
3. MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists.
French ED; Mura A; Wang T
Synapse; 1993 Feb; 13(2):108-16. PubMed ID: 8446919
[TBL] [Abstract][Full Text] [Related]
4. Competitive NMDA receptor antagonists attenuate phencyclidine-induced excitations of A10 dopamine neurons.
French ED
Eur J Pharmacol; 1992 Jun; 217(1):1-7. PubMed ID: 1397021
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute and chronic administration of phencyclidine on the A10 dopaminergic mesolimbic system: electrophysiological and behavioral correlates.
French ED
Neuropharmacology; 1988 Aug; 27(8):791-8. PubMed ID: 3216958
[TBL] [Abstract][Full Text] [Related]
6. Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system.
French ED; Pilapil C; Quirion R
Eur J Pharmacol; 1985 Oct; 116(1-2):1-9. PubMed ID: 2996909
[TBL] [Abstract][Full Text] [Related]
7. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
Gronier B; Debonnel G
Eur J Pharmacol; 1999 Mar; 368(2-3):183-96. PubMed ID: 10193654
[TBL] [Abstract][Full Text] [Related]
8. N-methyl-D-aspartic acid biphasically regulates the biochemical and electrophysiological response of A10 dopamine neurons in the ventral tegmental area: in vivo microdialysis and in vitro electrophysiological studies.
Wang T; O'Connor WT; Ungerstedt U; French ED
Brain Res; 1994 Dec; 666(2):255-62. PubMed ID: 7882036
[TBL] [Abstract][Full Text] [Related]
9. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.
Bristow LJ; Hutson PH; Thorn L; Tricklebank MD
Br J Pharmacol; 1993 Apr; 108(4):1156-63. PubMed ID: 8485625
[TBL] [Abstract][Full Text] [Related]
10. Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens.
Marcus MM; Mathé JM; Nomikos GG; Svensson TH
Neuropharmacology; 2001 Mar; 40(4):482-90. PubMed ID: 11249957
[TBL] [Abstract][Full Text] [Related]
11. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies.
Hutson PH; Barton CL; Jay M; Blurton P; Burkamp F; Clarkson R; Bristow LJ
Neuropharmacology; 2000 Sep; 39(12):2318-28. PubMed ID: 10974315
[TBL] [Abstract][Full Text] [Related]
12. Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons.
French ED; Ceci A
Neurosci Lett; 1990 Nov; 119(2):159-62. PubMed ID: 2280889
[TBL] [Abstract][Full Text] [Related]
13. N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis.
Koek W; Woods JH; Colpaert FC
J Pharmacol Exp Ther; 1990 Jun; 253(3):1017-25. PubMed ID: 2193142
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of ceruletide, a cholecystokinin analog, to the neurochemical effects of the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists, phencyclidine and MK-801, on regional dopaminergic neurons in the rat brain.
Kuroki T; Tatebayashi Y; Ide K; Yonezawa Y; Tsutsumi T; Matsumoto T; Hirano M; Uchimura H
Neuropeptides; 1992 Mar; 21(3):167-73. PubMed ID: 1385857
[TBL] [Abstract][Full Text] [Related]
15. Hyperactivity induced by N-methyl-d-aspartate injections into nucleus accumbens: lack of evidence for mediation by dopaminergic neurons.
O'Neill KA; Carelli RM; Jarvis MF; Liebman JM
Pharmacol Biochem Behav; 1989 Dec; 34(4):739-45. PubMed ID: 2560212
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat ventral tegmental dopamine neurons.
Wang T; French ED
Synapse; 1993 Mar; 13(3):270-7. PubMed ID: 7684531
[TBL] [Abstract][Full Text] [Related]
17. Effects of phencyclidine on spontaneous and excitatory amino acid-induced activity of ventral tegmental dopamine neurons: an extracellular in vitro study.
Wang T; French ED
Life Sci; 1993; 53(1):49-56. PubMed ID: 7685848
[TBL] [Abstract][Full Text] [Related]
18. Phencyclidine-induced activation of ventral tegmental A10 dopamine neurons is differentially affected by lesions of the nucleus accumbens and medial prefrontal cortex.
Ceci A; French ED
Life Sci; 1989; 45(7):637-46. PubMed ID: 2770418
[TBL] [Abstract][Full Text] [Related]
19. Genetic differences in the effects of competitive and non-competitive NMDA receptor antagonists on locomotor activity in mice.
Liljequist S
Psychopharmacology (Berl); 1991; 104(1):17-21. PubMed ID: 1831907
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist.
Bobelis DJ; Balster RL
J Pharmacol Exp Ther; 1993 Feb; 264(2):845-53. PubMed ID: 8437128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
